![Accountancy / Fundamental analysis / BSE Sensex / Cipla / Valuation / Motilal Oswal Group / Earnings before interest / taxes / depreciation and amortization / EV/EBITDA / Escitalopram / Finance / Financial ratios / Economics Accountancy / Fundamental analysis / BSE Sensex / Cipla / Valuation / Motilal Oswal Group / Earnings before interest / taxes / depreciation and amortization / EV/EBITDA / Escitalopram / Finance / Financial ratios / Economics](https://www.pdfsearch.io/img/2920b0d08a02f534d677f1e6c09b5141.jpg)
| Document Date: 2013-02-08 04:53:41 Open Document File Size: 214,17 KBShare Result on Facebook
City Indore / / Company Cipla No No No No / Cipla Cipla / U.S. Motilal Oswal Securities Limited / Cipla Medpro South Africa / P/E (x) Proposes / Meda / USD244m / Motilal Oswal Securities International Private Limited. / Singapore Motilal Oswal Capital Markets Singapore Pte Limited / Motilal Oswal Capital Markets Singapore Pte Limited / S&P / Teva / Bloomberg / USD350m / Motilal Oswal Securities Limited / / Continent Europe / / Country South Africa / Japan / United States / Australia / United Kingdom / Singapore / India / / Currency USD / / / Event Business Partnership / FDA Phase / M&A / Earnings Announcement / / IndustryTerm investment services / contract manufacturing services / pharmaceutical groups / registered broker / manufacturing / pharmaceutical policy / / Organization Federal Aviation Administration / African Government / U.S. Securities and Exchange Commission / FINRA / FDA / NASD / / Position registered broker / exempt financial advisor / independent financial advisor / research analyst / Financial Advisors Regulations / Major Institutional Investors / player / earnings driver / growth driver / registered investment adviser / Analyst / dominant player / dealer / / Product AIDS / 2QFY13 / Dymista / INR6b / 1HFY13 / / RadioStation Core / / Region South Africa / Middle East / / Technology API / CMP / /
SocialTag |